1 September 2016: Alzheimer Europe launches new service with up-to-date, accessible information on clinical trials
On 1 September 2016, Alzheimer Europe announced the launch of its Clinical Trials Watch, a new service bringing together up-to-date information on clinical trials investigating drugs for the treatment and prevention of Alzheimer’s and other dementias in an accessible format. To date, only phase III trials currently recruiting participants in at least two European countries are included. For this innovative new resource, Alzheimer Europe collaborated closely with members of its European Working Group of People with Dementia (EWGPWD) and consulted pharmaceutical companies conducting trials to present basic information. Information is given by country, study name and condition. Each study has been reviewed by a member of the EWGPWD and dementia-friendly versions are available for download. The content will be updated every three months based on information available on public registries. Jean Georges, Executive Director of Alzheimer Europe said: “Information on clinical trials on Alzheimer’s and other dementias is currently difficult to find and often written in language that is difficult to understand. We hope that our website will become a resource for anyone interested in clinical trials for the prevention and treatment of dementia. If successful, we hope to expand this resource to include phase II trials in the near future”. Helga Rohra, Chairperson of the EWGPWD, herself diagnosed with Lewy body dementia said: “With this new resource, we want to support people living with dementia in Europe in being truly informed about what research is available. This more dementia-friendly format is a great step in making information on clinical trials more accessible and understandable for people with dementia and people at risk of developing dementia.” About the Clinical Trials Watch Information on clinical trials is available on: http://www.alzheimer-europe.org/Research/Clinical-Trials-Watch Please note this information should not be interpreted as a recommendation to use a treatment, nor to participate in a study. For further information about the Clinical Trials Watch please contact Dr Ana Diaz, Project Officer: ana.diaz@alzheimer-europe.org
Keywords
Dementia, Alzheimer's disease, Clinical trial, Accessibility
Countries
Luxembourg